Keurig Dr Pepper KDP
Consumer Defensive · Beverages - Non-Alcoholic · Synthos Deep Dive · 2026-07-03
The Overview
Keurig Dr Pepper makes drinks you know: Dr Pepper, Snapple, 7UP, Canada Dry, Mott's, and the Keurig K-Cup coffee pods and machines. It is a big, steady "consumer staples" company — people buy soda and coffee in good times and bad, so the sales are dependable and the stock doesn't swing much.
Is the stock cheap or expensive? It is priced about right — not a bargain, not obviously overpriced. You are paying a fair price for a slow, dependable grower that pays a ~2.8% dividend (about $0.92 a year per share). Our verdict is Watch: there's nothing wrong with the company, but there's no obvious bargain and no fast-growth story, so most investors can simply keep an eye on it rather than rush to buy.
Here's what our three scores mean in everyday terms:
- Downside Risk 5/10 (middle). The business is stable and the stock is calm, but the company carries a lot of debt (about $15 billion) and is in the middle of a big, expensive coffee acquisition that adds risk.
- Growth Quality 5/10 (average). It grows, but slowly — and a lot of the growth on paper comes from buying other companies, not from selling more of its own drinks.
- Exponential Potential 3/10 (low). Soda and coffee are mature businesses. This is a tortoise, not a rocket — don't expect it to double quickly.
The one big worry: KDP is spending heavily (and borrowing) to buy a giant coffee company and then split itself into two companies. If that goes badly, the debt and disruption could hurt.
Putting a number on it: our fair-value estimate is $34 against a current price of $32.18 — real upside if our numbers are right.
Our summary metrics
Low beta 0.42 & defensive demand, but ~3.6× net-debt/EBITDA, 60% of assets in goodwill/intangibles, and a debt-funded transformation in flight.
Headline 15% fwd EPS CAGR is mostly acquisition, not organic; ROIC ~4% and 54% gross margin are pedestrian; moat is real but slow.
Mature staples compounder — growth is inorganic and decelerating on an organic basis; a $45B cap in a saturated category is no multibagger.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Mature staples compounder — growth is inorganic and decelerating on an organic basis; a $45B cap in a saturated category is no multibagger.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $33.40 (high $38 / low $28; 16 Buy · 12 Hold · 0 Sell) — context, not our anchor |
| Valuation | 24.7× trailing EPS · 14.6× FY26E · 13.2× FY27E · 10.6× FY30E · EV/S 4.1× · EV/EBITDA 17.3× |
| Technicals | Constructive — $33.30, −5.4% off 52-wk high, above 50/200-DMA, RSI 67, but −0.8% 12-mo vs SPY +21% / QQQ +30% |
| Conviction | None — 0 expert voices, 0 traceable claims in the Synthos KB; this call rests entirely on the numbers |
| Position sizing | If owned: small defensive/income satellite, ~1–2%, not a core growth holding |
What the experts actually said
No independent expert claims in the Synthos knowledge base yet for KDP — this dive is fundamentals- and technicals-driven, not panel-driven.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $32.18, 3% above the 50-day average ($31), 11% above the 200-day average ($29) — an uptrend. 4% below the 52-week high of $34, 27% above the 52-week low of $25.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $32.18 is currently inside the band (band $29–$33).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 58.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently above its signal line by 0.17, positive momentum.
Relative performance vs S&P 500 & its sector (XLP (sector)), set to 100 a year ago
Solid = KDP · dashed = S&P 500 · dotted = XLP (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
Keurig Dr Pepper (NASDAQ: KDP) is a North American beverage powerhouse formed by the 2018 merger of Keurig Green Mountain and Dr Pepper Snapple. It sells across four reporting units — Coffee Systems (Keurig brewers + K-Cup pods), Packaged Beverages (its own bottled/canned brands plus contract manufacturing and partner distribution), Beverage Concentrates (Dr Pepper, Canada Dry, A&W, 7UP, Sunkist, Snapple, Mott's, Bai and more), and Latin America Beverages. Headquarters in Frisco, TX; ~29,000 employees; CEO Timothy Cofer. Fiscal year ends December 31.
Revenue mix (FY2025, from filings):
- By product line: LRB (liquid refreshment beverages) $11.60B (70%) · K-Cup Pods $3.78B (23%) · Appliances (brewers) $0.65B · Other $0.58B. The story here: the cold-beverage (soda/juice/water) business is now the growth engine, while the coffee/pod franchise is a large, mature, high-margin cash cow that has been roughly flat.
- By geography: United States $14.50B (87%) · International $2.10B (13%). This is overwhelmingly a US business — a stability strength, but with little geographic diversification.
The strategic pivot to understand: KDP has announced a transformative expansion of its coffee business (a large coffee acquisition) and a plan to separate into two independent companies (a global coffee company and a North American beverages company). This is why the forward analyst estimates show revenue stepping up from ~$16.6B to ~$26B+ — that jump is largely inorganic (acquired scale), not underlying volume growth. Read the forward numbers with that caveat throughout.
2. The expert thesis (traceable)
There is no expert coverage of KDP in the Synthos knowledge base. total_claims = 0, net_bullish_voices = 0. No independent analyst or investor in our tracked panel has a distilled, traceable claim on this name.
That is stated plainly and by design: Synthos will never fabricate conviction. Where the KB is silent, we say so and fall back to fundamentals and quant. Everything in this note is derived from reported financials, FMP analyst consensus (labeled as estimates), and price/technical data — not from expert conviction. Readers should weight this note accordingly: it is a quantitative and fundamental read, not a high-conviction, expert-corroborated call like our flagship names.
3. Synthos scores
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 5 · Moderate | Beta 0.42 and defensive, non-cyclical demand cushion the downside, but ~$15.1B net debt (~3.6× FY25 EBITDA), 60% of assets in goodwill/intangibles, and a debt-funded acquisition + split in flight add balance-sheet and execution risk. Only fairly valued, so limited valuation cushion too. |
| Growth Quality | 5 · Average | 54% gross / 24% EBITDA margins are solid but unremarkable; ROIC ~4% and ROE ~7% are below what a great compounder shows. Headline ~15% forward EPS CAGR is mostly acquisition-driven — organic growth is mid-single-digit. |
| Exponential Potential | 3 · Low | Soda and single-serve coffee are mature, saturated categories. Growth is inorganic and decelerating organically; a $45B cap with no large untapped TAM is structurally not a multibagger. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. Instead the cases bound the range, and the scores above summarize them. Because the acquisition/split reshapes the share count and capital structure, we anchor the multiple to near-term (FY26–27E) earnings power rather than the post-deal FY30 figure.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Coffee deal integrates cleanly; the two-company split unlocks a sum-of-parts re-rating; organic LRB momentum continues. FY27E EPS beats toward ~$2.65; market pays a ~17× premium staples multiple. | ~$44 (+32%) |
| Base (our anchor) | Estimates roughly hit — FY27E EPS ~$2.52; a mid-single-digit organic compounder with a mature coffee arm earns a ~13.5× multiple in line with slow-growth staples peers. | ~$34 (+2%) |
| Bear | Integration friction, incremental leverage strains the dividend, or coffee volumes keep sliding. FY27E EPS misses toward ~$2.30; multiple de-rates to ~11× on balance-sheet worry. | ~$26 (−22%) |
Synthos fair value = the base case, ~$34 (+2%), with the full $26–$44 span as the honest range. This anchor sits essentially on top of the Street's $33.40 consensus — which is itself the point: at today's price the risk/reward is roughly symmetric and offers no margin of safety. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). KDP is neither an exponential nor an elite compounder — it is a mature staples cash machine:
- Forward growth: revenue CAGR FY25→FY30E ~15% ($16.6B → $33.3B); EPS CAGR ~15.4% ($1.53 → $3.13E). But the bulk of that revenue step-up is the coffee acquisition, not organic volume — strip the deal out and organic growth is mid-single-digit.
- Acceleration (the 2nd derivative): organically negative. Revenue was $14.06B (FY22) → $14.81B (FY23) → $15.35B (FY24) → $16.60B (FY25) — steady high-single-digit but not accelerating. The forward jump to $26B+ (FY26E) is a one-time inorganic step, after which growth reverts to mid-single-digit (FY28E $30.8B → FY29E $32.1B → FY30E $33.3B ≈ 4–5%/yr). This is deceleration dressed up by an acquisition.
- Room to run: the addressable market (US soda, water, juice, single-serve coffee) is large but mature and saturated, and KDP already holds top-tier share. There is no under-penetrated TAM that turns a $45B cap into a $200B cap. The law of large numbers plus category maturity caps the multibagger firmly.
- Reinvestment runway: modest — capex is only ~2.8% of revenue and ROIC is ~4%, so incremental reinvestment does not compound at attractive rates. Cash is largely returned via dividend (68% payout) rather than reinvested at high returns.
Exponential Potential: Low (3/10). Own KDP, if at all, for stability and income — not for growth and certainly not for a multibagger. This is the honest opposite of a flagship next-exponential.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY25 $16.60B, +8.2% (FY24 $15.35B, +3.6% on FY23 $14.81B). Steady mid-to-high-single-digit organic growth — dependable, not exciting.
- Quarterly trajectory: Q1'25 $3.64B → Q2 $4.16B → Q3 $4.31B → Q4 $4.50B → Q1'26 $3.98B (+9.4% YoY vs Q1'25). Normal beverage seasonality (summer-heavy); YoY comps stay positive.
- Margins: gross 54.2%, EBITDA ~24%, operating ~21%, net ~10.8% TTM. Healthy for a beverage company but far below a premium-moat compounder.
- Earnings: net income $2.08B FY25 (up from $1.44B FY24, which was depressed by a large Q4'24 charge — note the −$0.11 Q4'24 EPS); EPS $1.53 FY25. Q1'26 net income $270M (EPS $0.20).
- Cash flow: operating CF $1.99B, capex −$0.49B, FCF $1.51B FY25 (down from $1.66B FY24 as working capital consumed ~$1.0B — inventory and receivables build). FCF comfortably covers the ~$1.25B dividend, but not by a huge margin.
- Balance sheet: total debt $16.1B, net debt $15.1B. Against FY25 EBITDA of $4.19B that is ~3.6× net-debt/EBITDA — investment-grade but genuinely levered, and set to rise with the coffee acquisition. (Note: the FMP TTM metric shows 6.1× because it divides by a depressed trailing EBITDA base; the cleaner FY25-EBITDA figure of ~3.6× is the fairer read, and we flag both.) Goodwill + intangibles are $44.0B — ~79% of total assets and equity is heavily intangible (tangible book value is negative). This is an acquisition-built balance sheet.
6. Valuation — priced in or room?
KDP screens as fairly valued, not cheap and not expensive. Trailing 24.7× EPS, 4.1× EV/sales, 17.3× EV/EBITDA, ~2.8% dividend yield. On forward consensus the P/E compresses to 14.6× (FY26E) → 13.2× (FY27E) → 10.6× (FY30E) — but remember that compression is powered largely by acquired earnings, so it flatters the organic multiple. Stripped of the deal, KDP trades at a normal staples multiple for a normal staples grower. The FMP letter rating is B (overall score 3/5), with its weakest sub-scores on debt-to-equity and P/E — consistent with our read. Street targets (context): consensus $33.40, high $38, low $28, with a Buy/Hold split (16 Buy, 12 Hold, no Sells). Our base-case fair value (~$34) essentially matches consensus, which is exactly why the verdict is Watch: at $33.30 you are paying fair value with no discount, so the reward for the transformation risk is thin.
7. Technicals (computed from EOD price history)
- Trend: up. $33.30 sits above the 50-DMA ($30.16) and 200-DMA ($28.15), with the 50 above the 200 (golden-cross posture). MACD +0.91 (positive).
- Location: −5.4% off the 52-week high ($35.20), +31.6% off the 52-week low ($25.30). Max drawdown from peak was a modest −16.9%.
- Momentum: RSI(14) 66.6 — strong, approaching but not through the 70 overbought line. Not a stretched entry, but not a washed-out one either.
- Relative strength (the tell — and it's a caution): KDP is −0.8% over 12 months while SPY is +20.6% and QQQ is +30.3%. It has recovered sharply short-term (+29.6% 3-mo vs SPY +13.7%), but over a full year it has badly lagged the market. A low-beta defensive that trails a rising market is behaving exactly as you'd expect — which reinforces that this is a stability/income holding, not a growth leader.
- Read: technicals are constructive short-term (uptrend, above both moving averages, recovering) but the 12-month underperformance vs both SPY and QQQ underlines the fundamental story: dependable, not dynamic.
8. Moat & competitive position
KDP's moat is real but narrow: (1) iconic brands with durable shelf presence (Dr Pepper is a genuine share-gainer in US carbonated soft drinks; Snapple, Canada Dry, Mott's, 7UP anchor the portfolio); (2) the Keurig razor-and-blades coffee ecosystem — an installed base of brewers that pulls recurring high-margin K-Cup pod sales, though the pod patent cliff long ago opened the door to private-label competition; (3) distribution scale across DSD and warehouse channels. The weaknesses: it is a clear #3 behind Coca-Cola and PepsiCo in beverages and faces private-label and single-serve-coffee competition (Nespresso, store brands) on the pod side. Returns on capital (~4% ROIC) confirm the moat monetizes at ordinary, not premium, rates.
Peer set (market cap): the FMP peer list skews to consumer-staples adjacents rather than pure beverage rivals — Coca-Cola Europacific Partners $47B, Ambev $48B, Sysco $41B, Kimberly-Clark $38B, Kenvue $38B, Hershey $37B, Kroger $36B, Estée Lauder $30B, Kellanova $29B, Target $59B. The more relevant strategic comps (not in the FMP list) are Coca-Cola and PepsiCo, both far larger and higher-return. Within this staples cohort KDP is mid-pack on growth and multiple.
9. Management, capital allocation & guidance
- Capital allocation: dividend-first. FY25 paid ~$1.25B in dividends (68% payout, ~2.8% yield) with only token buybacks (~$9M net). Capex is light (~$0.49B). The defining capital decision now is the large, partly debt-funded coffee acquisition and the planned two-way corporate separation — a bold, transformative use of the balance sheet that will raise leverage before it (hopefully) unlocks value. This is the swing factor for the entire thesis.
- Insider activity: the sampled Form 4s are routine — RSU vesting, tax-withholding ("F-InKind") dispositions, and award grants for the CEO (Cofer), the Controller, and the Coffee-unit CEO, plus a new director's Form 3 (Driscoll, 2026-06-16). No cluster of alarming open-market discretionary selling in the window — normal compensation mechanics.
- Guidance: no management claims are ingested into the Synthos KB for KDP (breadth 0). Forward figures in this note are FMP analyst consensus, labeled as estimates. Gap flagged: management's own dated guidance and the acquisition/split economics are not yet in our KB for this name — a coverage gap to close before any conviction upgrade.
10. Catalysts & what to watch
- Next earnings: 2026-08-06 (Q2'26; Street EPS $0.55, revenue ~$7.25B — note the revenue estimate already reflects post-acquisition scale). Watch organic volume/mix vs price, and coffee/pod volume trend.
- Coffee acquisition + corporate split: deal close, financing terms, incremental leverage, and the timeline/structure of the two-company separation — the single biggest swing factor for the stock.
- Leverage & the dividend: net-debt/EBITDA trajectory post-deal; any signal on dividend safety.
- US carbonated soft drink share: Dr Pepper's continued share gains vs Coke/Pepsi.
- Input costs & FX: coffee (green coffee, aluminum) and packaging inflation; the small international book.
Thesis tripwires (what would change the call): integration missteps or a deal price that pushes net-debt/EBITDA meaningfully above ~4×; two consecutive quarters of organic volume declines; FCF falling below dividend coverage; or a de-rating that finally opens a real valuation discount (which would flip Watch → Buy).
11. Key risks
- Transformation / balance-sheet risk (structural): a large, debt-funded coffee acquisition plus a corporate split on top of ~$15B existing net debt — integration, execution, and leverage risk all at once.
- No valuation cushion: at ~$33 the stock trades at our fair value and at Street consensus, so there is little margin of safety if anything slips.
- Mature, competitive categories: US soda and single-serve coffee are saturated; private-label pods and the Coke/Pepsi duopoly cap pricing power.
- Low returns on capital: ROIC ~4%, ROE ~7% — the business does not compound reinvested capital at attractive rates.
- Intangible-heavy balance sheet: ~79% of assets are goodwill/intangibles; tangible book is negative, so impairment risk exists if any acquired brand underperforms.
- No expert corroboration: zero KB coverage means this call has no independent-conviction backstop — it lives or dies on the quant/fundamental read alone.
12. Verdict, position sizing & monitoring
Watch. KDP is a competently run, low-beta beverage staple that produces dependable cash flow and a ~2.8% dividend — but it is only fairly priced (our ~$34 base case ≈ the $33.30 quote ≈ the $33.40 Street consensus), its returns on capital are ordinary, its growth is largely inorganic and organically decelerating, and it is mid-way through a leveraged, transformative coffee acquisition and corporate split that adds real risk without an offsetting discount in the price. There is no expert conviction in the Synthos KB to lean on. That combination — good company, no bargain, no exponential upside, elevated near-term corporate risk — is the textbook definition of Watch, not Buy.
- Sizing: if owned, treat it as a small defensive/income satellite, ~1–2% — a stability sleeve, not a core growth position. There is no case here for a large, high-conviction weight.
- What would change the call: a real valuation discount (a de-rate toward the low-$20s with the dividend intact), clear evidence the coffee deal/split is unlocking value, or the emergence of tracked expert conviction — any of which could flip this to Buy — Tactical.
- Monitoring: re-underwrite on the tripwires in §10; formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $33.30.
- Single biggest risk: the debt-funded coffee acquisition and planned corporate split — integration and balance-sheet strain on an already-levered staples business.
Provenance & disclosures
- Traceability: 0 KB claims, breadth 0 — no expert coverage in the Synthos KB for KDP. This is stated plainly; conviction is neither claimed nor fabricated. The verdict is fundamentals- and quant-driven.
- Data as-of: fundamentals 2026-03-31 (Q1'26) · estimates & prices 2026-07-02/03 · no expert claims. Forward figures are analyst consensus (FMP), labeled as estimates; note the forward revenue step-up is largely acquisition-driven, not organic.
- Balance-sheet caveat: the FMP TTM net-debt/EBITDA of 6.1× uses a depressed trailing EBITDA base; the cleaner FY25-EBITDA figure (~3.6×) is used as the fairer read and both are disclosed.
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").